Effects of intravascular contrast media on urinary excretion of liver fatty acid-binding protein

Japanese Journal of Nephrology

Volumn 47, Issue 4, 2005, Pages 437-444

  Ohta, Satoshi ^a   Ishimitsu, Toshihiko ^a   Minami, Junichi ^a   Ono, Hidehiko ^a   Matsuoka, Hiroaki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiography; Contrast media nephropathy; Liver fatty acid binding protein; N acetyl D glucosaminidase; Proximal tubule

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA 1 MICROGLOBULIN; ASPARTATE AMINOTRANSFERASE; BETA 2 MICROGLOBULIN; CREATININE; FATTY ACID BINDING PROTEIN; IODINATED CONTRAST MEDIUM; LIVER FATTY ACID BINDING PROTEIN; MESSENGER RNA; N ACETYL BETA GLUCOSAMINIDASE; SODIUM; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGRAPHY; AORTA VALVE REGURGITATION; ARTICLE; CLINICAL ARTICLE; CONTRAST MEDIUM NEPHROPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; KIDNEY PROXIMAL TUBULE; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN URINE LEVEL; STRESS; URINARY EXCRETION; URINE VOLUME;

ACETYLGLUCOSAMINIDASE; BIOLOGICAL MARKERS; CARRIER PROTEINS; CONTRAST MEDIA; FATTY ACID-BINDING PROTEINS; HUMANS; IODINE; KIDNEY DISEASES; KIDNEY TUBULES, PROXIMAL;

EID: 21844445848     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Arici M, Chana R, Lewington A, Brown J, Brunskill NJ. Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma. J Am Soc Nephrol 2003; 14: 17-27.
2. Thomas ME, Schreiner GF. Contribution of proteinuria to progressive renal injury: consequences of tubular uptake of fatty acid bearing albumin. Am J Nephrol 1993; 13: 385-398.
3. Thomas ME, Morrison AR, Schreiner GF. Metabolic effects of fatty acid-bearing albumin on a proximal tubule cell line. Am J Physiol 1995; 268: F1177-F1184.
4. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hase H, Kaneko T, Hirata Y, Goto A, Fujita T, Omata M. Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int 2002; 62: 1628-1637.
5. Veerkamp JH, Peelers RA, Maatman RG. Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim Biophys Acta 1991; 1081: 1-24.
6. Schroeder F, Jolly CA, Cho TH, Frolov A. Fatty acid binding protein isoforms: structure and function. Chem Phys Lipids 1998; 92: 1-25.
7. Wolfrum C, Borrmann CM, Horchers T, Spener F. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc Natl Acad Sci USA 2001; 98: 2323-2328.
8. Mandard S, Muller M, Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci 2004; 61: 393-416.
9. Corton JC, Anderson SP, Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Ann Rev Pharmacol Toxicol 2000; 40: 491-518.
10. Maatman RG, van de Westerlo EM, van Kuppevelt TH, Veerkamp JH. Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J 1992; 288: 285-290.
11. Walker PD, Shah SV. Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J Clin Invest 1988; 81: 334-341.
12. Meunier-Durmort C, Poirier H, Niot I, Forest C, Besnard P. Up-regulation of the expression of the gene for liver fatty acid-binding protein by long-chain fatty acids. Biochem J 1996; 319: 483-487.
13. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hikawa A, Hirano N, Hirata Y, Goto A, Omata M. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 2004; 143: 23-30.
14. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
15. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol 1994; 5: 125-137.
16. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Contrast media-associated nephrotoxicity. Semin Nephrol 1997; 17: 15-26.
17. Solomon R. Contrast-medium-induced acute renal failure. Kidney Int 1998; 53: 230-242.
18. Kamijo A, Kimura K, Sugaya T, Hikawa A, Yamanouchi M, Hirata Y, Goto A, Fujita T, Omata M. Urinary excretion of liver type fatty acid binding protein (L-FABP) is a new clinical marker for prognosis of chronic glomerular disease, (abstr) J Am Soc Nephrol 2001; 12(Suppl): 74A.
19. Ishimitsu T, Ohta S, Saiyo M, Teranishi M, Inada H, Yoshii M, Minami J, Ono H, Hikawa A, Shibata N, Sugaya T, Kamijo A, Kimura K, Ohrui M, Matsuoka H. Urinary excretion of liver fatty acid-binding protein in health-check participants. Clin Exp Nephrol 2005; 9: 34-39.
20. Risdon RA, Sloper JC, De Wardener HE. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968; 2: 363-366.
21. Eisenberg RL, Bank WO, Hedgock MW. Renal failure after major angiography can be avoided with hydration. Am J Roentgenol 1981; 136: 859-861.
22. Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer DC, Guido-Allen DA, Timmis GC, O'Neill WW. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P. R. I. N. C. E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol 1999; 33: 403-411.
23. Moon SS, Back SE, Kurkus J, Nilsson-Ehle P. Hemodialysis for elimination of the nonionic contrast medium iohexol after angiography in patients with impaired renal function. Nephron 1995; 70: 430-437.
24. Hans SS, Hans BA, Dhillon R, Dmuchowski C, Glover J. Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency. Am Surg 1998; 64: 432-436.
25. Kapoor A, Sinha N, Sharma RK, Shrivastava S, Radhakrishnan S, Goel PK, Bajaj R. Use of dopamine in prevention of contrast induced acute renal failure-a randomised study. Int J Cardiol 1996; 53: 233-236.
26. Sketch MH Jr, Whelton A, Schollmayer E, Koch JA, Bernink PJ, Weltering F, Brinker J. Prostaglandin E1 Study Group. Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled study. Am J Ther 2001; 8: 155-162.
27. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184.
28. Morcos SK. Prevention of contrast media nephrotoxicity - the story so far. Clin Radiol 2004; 59: 381-389.
29. Cox CD, Tsikouris JP. Preventing contrast nephropathy: what is the best strategy? A review of the literature. J Clin Pharmacol 2004; 44: 327-337.